Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local insulin injection for prevention of excessive scarring after bilateral breast surgery
ISRCTN51295799Phase 2Completed
- Sponsor
- Pharmecosse
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, double-blind trial in pathological scarring (PS) and Hypertrophic Scar (HS) comparing Local insulin injection wound with Local placebo injection wound (2 arms). Primary endpoint: Severity of scar formation at 12 months. Started Oct 2010; status: completed.
02
Drugs
human insulin
03
Conditions
pathological scarring (PS)Hypertrophic Scar (HS)
Beyond the preview
Go deeper on ISRCTN51295799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN51295799.